To this end, we investigated the expression of GNLY in the lesional and perilesional skin of vitiligo and halo nevus, its localisation in different skin compartments and colocalisation with CD8+ and CD56+ antigens to identify the cells expressing this cytotoxic molecule and the potential sites of immune response. The gene discussed is CD8A; the disease is vitiligo.